2016. IASLC World Conference on Lung Cancer – Have we shifted the therapeutic innovation frontier? A US assessment of advanced non–small cell lung cancer (advNSCLC)

Korytowsky B, Justo N, Nilsson,J, Madison T, Dalen J, McGuire A. Have we shifted the therapeutic innovation frontier? A US assessment of advanced non–small cell lung cancer (advNSCLC). J Thorac Oncol. 2016;11(11S):S316-S317. PS01.73. Presented at IASLC 17th World Conference on Lung Cancer 2016; December 4-7, 2016; Vienna, Austria.